Embecta Corp. (EMBC)

↓ Download CSV

CIK 0001872789 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Sep 30

In fiscal 2025, Embecta Corp. reported revenue of $1.08B, down 3.8% from the prior year. The company was profitable, with a net margin of 8.8% and a gross margin of 62.6%.

Key ratios (FY2025)

62.6%
Gross margin
22.4%
Operating margin
8.8%
Net margin
-3.8%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019
Revenue$1.08B$1.12B$1.12B$1.13B$1.17B$1.09B
Cost of Revenue$403.60M$387.90M$370.90M$354.60M$364.90M$322.90M
Gross Profit$676.80M$735.20M$749.90M$774.90M$800.40M$762.60M
Operating Income$242.10M$166.80M$221.50M$309.60M$492.00M$486.50M
Net Income$95.40M$78.30M$70.40M$223.60M$414.80M$427.60M
EPS (Diluted)$1.62$1.34$1.22$3.89$7.28$7.50
Total Assets$1.09B$1.29B$1.21B$1.09B$788.00M
Shareholders' Equity-$650.60M-$738.30M-$821.70M-$891.40M$594.30M$572.20M$577.10M
Cash & Equivalents$225.50M$267.50M$326.30M$330.90M$0
Operating Cash Flow$191.70M$35.70M$67.70M$412.20M$456.30M$498.50M
Capital Expenditures$9.30M$15.80M$26.50M$23.60M$36.80M$41.90M
Shares Outstanding58.91M58.33M57.76M57.46M57.01M57.01M
Dividends Per Share$0.60$0.60$0.60$0.15